Success Metrics

Clinical Success Rate
75.0%

Based on 6 completed trials

Completion Rate
75%(6/8)
Active Trials
1(10%)
Results Posted
0%(0 trials)
Terminated
2(20%)

Phase Distribution

Ph early_phase_1
1
10%
Ph not_applicable
8
80%
Ph phase_4
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(6)
Terminated(2)
Other(1)

Detailed Status

Completed6
Terminated2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (10.0%)
Phase 41 (10.0%)
N/A8 (80.0%)

Trials by Status

recruiting110%
completed660%
terminated220%
unknown110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10